Foresta Group Holding (FGH) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
26 Mar, 2026Executive summary
Transitioned from concept to execution with groundwork for flagship biomass facility in Kawerau, NZ, including a 30-year lease, resource consent for Stage 1, and geotechnical investigations completed.
Secured inclusion in NZ's Fast-Track Approvals Act 2024, expediting consenting and construction timelines.
Signed non-binding term sheet with Genesis Energy for torrefied wood pellets and LOI with Lawter (NZ) for pellets, rosin, and turpentine.
Exclusive technology license with E3 Carbon enables advanced torrefaction processes and multiple revenue streams.
Raised $2.575M in convertible notes and $1.15M placement at a 25% premium to pre-suspension prices.
Financial highlights
Operating loss for FY2025 was $3,375,115, a significant improvement from $9,650,145 loss in FY2024.
Cash and cash equivalents at year-end were $1,199,115, up from $185,748 in the prior year.
Total assets increased to $4,165,803 from $3,761,668 year-over-year.
Net assets at 30 June 2025 were $1,272,260, down from $1,590,813 at 30 June 2024.
No dividends declared or paid for the year.
Outlook and guidance
Focus for FY2026 is to secure funding to commence construction of the Kawerau facility.
Ongoing efforts to stabilise the company, optimise cash flow, and advance project funding.
Committed to delivering sustainable value and leading the transition to bio-based energy and chemicals.
Latest events from Foresta Group Holding
- Losses deepened as project development advanced, with funding and legal risks persisting.FGH
H2 202426 Mar 2026 - Losses widened despite higher revenue and cash, with funding and legal risks persisting.FGH
H1 20265 Mar 2026 - Advanced Kawerau project but faces urgent capital needs with less than two quarters' cash.FGH
Q4 2024 TU8 Jan 2026 - Flagship project gains fast-track status as cash reserves fall and capital raising intensifies.FGH
Q1 2025 TU8 Jan 2026 - Convertible note and equity raise boost liquidity, but funding runway remains tight.FGH
Q2 2025 TU8 Jan 2026 - Loss narrowed, funding secured, and NZ project fast-tracked, but going concern risk persists.FGH
H1 20258 Jan 2026 - Major project milestones achieved and $2M raised, enabling next phase of development.FGH
Q3 2025 TU8 Jan 2026 - Regulatory extension and geothermal collaboration drive project progress amid tight cash runway.FGH
Q4 2025 TU8 Jan 2026 - Final $2.4M insurance settlement boosts cash to $2.82M; Kawerau Plant advances.FGH
Q1 2026 TU8 Jan 2026